Back to GL GLENVIEW CAPITAL MANAGEMENT, LLC

TEVATEVA
Showing 8 of 11 quarters

Position history for GLGLENVIEW CAPITAL MANAGEMENT, LLC's holdings in TEVA PHARMACEUTICAL-SP ADR

GLENVIEW CAPITAL MANAGEMENT, LLC holds 5.1M shares of TEVA (TEVA PHARMACEUTICAL-SP ADR), worth $172.1M as of 2026-Q2. The position was decreased (-23.7% shares). TEVA represents 3.1% of GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$172.1M

Current Shares

5.1M

Total Value Change

+$19.8M

Total Shares Change

-3.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.1M
-23.7%
$172.1M3.1%$33.88
0
2026-Q1
Decreased
6.7M
-60.2%
$200.6M5.0%$32.28
0
2025-Q4
Increased
16.7M
+0.2%
$521.8M10.6%$31.34
61
2025-Q3
Increased
16.7M
+5.5%
$337.2M7.5%$19.18
64
2025-Q2
Increased
15.8M
+7.1%
$265.2M7.4%$16.76
65
2025-Q1
Increased
14.8M
+74.8%
$227.1M5.6%$15.08
91
2024-Q4
Unchanged
8.5M
0.0%
$186.4M4.7%$22.32
0
2024-Q3
Decreased
8.5M
-7.7%
$152.4M2.9%$17.46
0

Other major holders of TEVA: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used